
2021 Impact Factor of CJCR: 4.026
Journal Citation Reports®, Clarivate Analytics

National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
National Health Commission of the People’s Republic of China

CSCO guidelines for colorectal cancer version 2022: Updates and discussions
Colorectal cancer (CRC) is the third most common cancer worldwide and the second most common in tumor-related mortality by Global Cancer Statistics 2020. Recent data show that the incidence and mortality of CRC in China are increasing, with the number of new cases and deaths reaching 607,900 and 261,777 in 2019. The Chinese Society of Clinical Oncology (CSCO) published the first version guidelines in April 2017 and updated annually according to the latest clinical data and the changes in China’s national conditions. Here we present the main updates of the 2022 version compared with the previous version.

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)
Lymphomas are a group of heterogeneous diseases, which is divided into two main categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). There is an estimated 75,400 incidence cases and 40,500 deaths annually in China, of which NHL accounts for about 90% of lymphoma burden.

Attributable deaths of liver cancer in China
Liver cancer is the sixth most commonly diagnosed cancer and the third cancer-related death worldwide, with 905,677 cases and 830,180 deaths in 2020. Of these, nearly 45.3% of new cases and 47.1% of deaths occurred in China. Several epidemiological studies have identified several risk factors associated with liver cancer, including chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), alcohol consumption, tobacco use, metabolic diseases such as obesity and diabetes. Of which, HBV and HCV, primary risk factors for liver cancer in China, have contributed to the most substantial proportion of liver cancer burden in China. Studies have also shown that liver cancer burden varies significantly across regions and sex due to the heterogeneous exposure of risk factors. In this study provide detailed results of the liver cancer burden in the Chinese population attributable to HBV, HCV, diabetes, excess bodyweight, alcohol drinking, tobacco smoking, and Clonorchis sinensis in 2014 stratified by age groups, sex, and provinces. HBV still contributes to the majority of liver cancer burden than any other risk factors.